Skip to content

Analysis of Risk factors for Retinopathy of Prematurity in AGA vs SGA Preterm infants

Analysis of Risk factors for Retinopathy of Prematurity in AGA vs SGA Preterm infants in a Tertiary Care hospital in Karnataka

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/04/024682
Enrollment
175
Registered
2020-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H351- Retinopathy of prematurity

Interventions

None listed

Sponsors

Dr Arya Sandesh Wagle
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All babies with gestational age (GA) at birth of �36 weeks and a BW of �2000 g or neonates born with 36 weeks gestation or birth weight above 2000 g who are at risk of developing ROP shall be included: ANTENATAL: Use of Antenatal steroids, Multiple gestation (monochorionic vs dichorionic twins), Antenatal Neuroprotection (use of Magnesium Sulphate), Chorioamnionitis leading to preterm birth, use of ART (assisted reproductive technology) for conception NATAL: Resuscitation at birth, Poor APGAR score, Intraventricular Haemorrhage, Low birth weight, location of birth (hospital birth or home birth) POSTNATAL: Poor weight gain velocity in the early postnatal period, use of pulmonary surfactant for RDS (respiratory distress syndrome), exposure to Oxygen therapy, Packed RBC (red blood cell) transfusion, use of Erythropoietin, PDA (patent ductus arteriosus), NEC (necrotising enterocolitis), recurrent Apnoea, Postnatal supplementation with PPN (partial parenteral nutrition), Culture proven Sepsis, Early postnatal hyperglycaemia

Exclusion criteria

Exclusion criteria: Babies with incomplete hospital documentation of pre and perinatal comorbidities will be excluded Babies with incomplete data on BW or GA will also be excluded Babies who died before complete resolution of ROP or did not attend the outpatient clinic for follow-up examinations will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Analysis and comparison of the risk factors and severity of ROP with gestational categorization (AGA versus SGA)Timepoint: assessment of the outcome shall be carried out at the end of the study period

Secondary

MeasureTime frame
Analysis and comparison of the risk factors and severity of ROP as AGA versus SGATimepoint: 1 year

Countries

India

Contacts

Public ContactDr Sulatha V Bhandary

Kasturba Hospital Manipal

sulatha.bhandary@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026